Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Hydrogel-nanoparticle delivery platform for LOCALized CAR-M immunotherapy

Objective

LOCAL-CAR is a Proof-of-Concept project aimed at validating a modular hydrogel-based platform for localized mRNA immunotherapy, targeting peritoneal tumor burden in ovarian and colorectal cancer models. Building on ERC-funded technologies – ABGel and aNP-mRNA – the project integrates these into a single ABGel-mRNA system for sustained intraperitoneal immunotherapy. The platform will generate HER2-CAR-expressing macrophages (CAR-M) directly within the peritoneal cavity, enabling local anti-HER2-tumor activity.
The project objectives are: (1) optimize ABGel-mRNA formulations encoding HER2-CAR constructs and screen their ability to generate functional CAR-M in vitro; (2) evaluate in vivo CAR‑M induction and therapeutic efficacy in mouse ovarian and colorectal cancer models; (3) develop IP strategy and expand patent portfolio; (4) conduct market analysis and engage stakeholders in the emerging in vivo CAR therapy landscape; and (5) disseminate findings and build strategic partnerships. Co-applicant BioTrip supports IP management, regulatory strategy, and commercialization. LOCAL-CAR addresses a critical unmet need in oncology and offers a scalable, biocompatible solution with broad translational potential in immunotherapy, autoimmune diseases, and vaccination.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2026-POC

See all projects funded under this call

Host institution

TECHNISCHE UNIVERSITEIT EINDHOVEN
Net EU contribution
€ 125 000,00
Address
GROENE LOPER 3
5612 AE Eindhoven
Netherlands
Region
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (2)